Cyclotron Produced Radionuclides for Diagnosis and Therapy of Human Neoplasms
This project funded since 1986 serves as a core project for cancer research throughout MSKCC, producing key radiotracers as well as basic knowledge about thel physics of radiation decay and imaging, for nuclear medicine applications to cancer diagnosis and therapy. In recent years this research application has broadened to include experiments intended to lead to an improved understanding of cancer biology and into the discovery and testing of new cancer drugs. Advances in immune based radiotargeting form the basis for this project. Both antibody and cellular based immune targeting methods have been explored. The multi-step targeting methodologies (MST) developed by NeoRex (Seattle,Washington), have been adapted for use with positron emitting isotopes and PET allowing the quantification and optimization of targeted delivery. In addition, novel methods for radiolabeling immune T-cells with PET tracers have advanced our ability to track these cells of prolonged period of time.
- Research Organization:
- Sloan-Kettering Institute for Cancer Research
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-86ER60407
- OSTI ID:
- 964282
- Report Number(s):
- DOE/ER/60407; TRN: US1002786
- Country of Publication:
- United States
- Language:
- English
Similar Records
Production of Medically Important Radionuclides 52Mn and 90Nb
Improving cancer treatment with cyclotron produced radionuclides